Literature DB >> 18689375

Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study.

Teresa Norat1, Richard Bowman, Robert Luben, Ailsa Welch, Kay Tee Khaw, Nick Wareham, Sheila Bingham.   

Abstract

BACKGROUND: Intervention studies have indicated an interaction between the blood pressure response to a low-sodium or a low-fat and high-fruit and -vegetable diet and the angiotensinogen gene (AGT) polymorphisms G-6A and M235T.
OBJECTIVE: We investigated whether this interaction is also present in a large free-living population.
DESIGN: Urinary sodium, potassium as biomarkers of intake, and blood pressure were measured in 11 384 men and women aged 45-79 y participating in the Norfolk arm of the European Prospective Investigation of Nutrition and Cancer (EPIC). The M235T polymorphism was assessed by pyrosequencing.
RESULTS: Highly significant associations between sodium and blood pressure were shown for all genotypes (P < 0.001), but the regression coefficient for systolic blood pressure associated with each unit of sodium for each of the MT and TT genotypes was approximately double that for the MM homozygotes (P < 0.001 for heterogeneity between genotypes). Differences were evident at high exposures to sodium but not at low exposures. There were no significant associations between blood pressure and dietary or urinary potassium.
CONCLUSIONS: This large cross-sectional study supports public health recommendations to reduce salt consumption in the population as a whole, and it confirms intervention trial data showing the greatest response to intervention in persons with the AA and TT genotype in the AGT G-6A and M235T polymorphisms. Genotype effects in populations at low exposure to sodium are not likely to be seen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689375     DOI: 10.1093/ajcn/88.2.392

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  16 in total

Review 1.  Biomarkers in nutritional epidemiology: applications, needs and new horizons.

Authors:  Mazda Jenab; Nadia Slimani; Magda Bictash; Pietro Ferrari; Sheila A Bingham
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

Review 2.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

3.  Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

Authors:  Pablo Pérez-Martínez; Dimitri P Mikhailidis; Vasilios G Athyros; Mónica Bullo; Patrick Couture; María I Covas; Lawrence de Koning; Javier Delgado-Lista; Andrés Díaz-López; Christian A Drevon; Ramón Estruch; Katherine Esposito; Montserrat Fitó; Marta Garaulet; Dario Giugliano; Antonio García-Ríos; Niki Katsiki; Genovefa Kolovou; Benoît Lamarche; Maria Ida Maiorino; Guillermo Mena-Sánchez; Araceli Muñoz-Garach; Dragana Nikolic; José M Ordovás; Francisco Pérez-Jiménez; Manfredi Rizzo; Jordi Salas-Salvadó; Helmut Schröder; Francisco J Tinahones; Rafael de la Torre; Ben van Ommen; Suzan Wopereis; Emilio Ros; José López-Miranda
Journal:  Nutr Rev       Date:  2017-05-01       Impact factor: 7.110

4.  Genetic susceptibility to salt-sensitive hypertension in a Han Chinese population: a validation study of candidate genes.

Authors:  Zheng Liu; Han Qi; Bin Liu; Kuo Liu; Jingjing Wu; Han Cao; Jie Zhang; Yuxiang Yan; Yan He; Ling Zhang
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

5.  Effect of GPE-AGT nanoparticle shRNA transfection system mediated RNAi on early atherosclerotic lesion.

Authors:  Ping Lu; Lifen Yuan; Yuqiang Wang; Qin Du; Jing Sheng
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

Review 6.  Genomics and Pharmacogenomics of Salt-sensitive Hypertension.

Authors:  Ines Armando; Van Anthony M Villar; Pedro A Jose
Journal:  Curr Hypertens Rev       Date:  2015

Review 7.  Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact.

Authors:  Mark J Pletcher; Michael Pignone
Journal:  Circulation       Date:  2011-03-15       Impact factor: 29.690

8.  Genomics and pharmacogenomics of salt-sensitive hypertension Minireview.

Authors:  Ines Armando; Van Anthony M Villar; Pedro A Jose
Journal:  Curr Hypertens Rev       Date:  2015

Review 9.  Nutrigenomics in cardiovascular medicine.

Authors:  Dolores Corella; Jose M Ordovas
Journal:  Circ Cardiovasc Genet       Date:  2009-12

10.  Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals.

Authors:  Andrew D Johnson; Christopher Newton-Cheh; Daniel I Chasman; Georg B Ehret; Toby Johnson; Lynda Rose; Kenneth Rice; Germaine C Verwoert; Lenore J Launer; Vilmundur Gudnason; Martin G Larson; Aravinda Chakravarti; Bruce M Psaty; Mark Caulfield; Cornelia M van Duijn; Paul M Ridker; Patricia B Munroe; Daniel Levy
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.